Asymptomatische Bakteriurie: wen screenen – und wen behandeln?

• Literatur

• 1 Schmiemann G, Hoyme U, Hummerspradier E et al. Epidemiologie, Diagnostik, Therapie und Management unkomplizierter bakterieller ambulant erworbener Harnwegsinfektionen bei erwachsenen Patienten. S-3 Leitlinie der Arbeitsgemeinschaft Wissenschaftlicher Medizinischer Fachgesellschaften (AWMF). AWMF-Register-Nr 043/044, 2010
• 2 Grabe M, Botto H, Wullt B et al. Guidelines on urological infections. In: EAU ed. European Association of Urology Guidelines. Arnhem, The Netherlands: European Association of Urology; 2010: 1-110
• 3 Nicolle LE, Bradley S, Colgan R et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005; 40: 643-54
• 4 Hooton TM, Bradley S, Cardenas DD et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis 2010; 50: 625-663
• 5 Christiaens TCM, De Meyere M, Verschraegen G et al. Randomised controlled trial of nitro-furantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women. Br J Gen Prac 2002; 52: 729-734
• 6 Ferry S, Holm SE, Stenlund H et al. Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: the LUTIW project. Scand J Prim Health Care 2007; 25: 49-57
• 7 Klemm P, Roos V, Ulett GC et al. Molecular Characterization of the Escherichia coli Asymptomatic Bacteriuria Strain 83972: the Taming of a Pathogen. Infect Immun 2006; 74: 781-785
• 8 Salvador E, Wagenlehner F, Köhler C-D et al. Comparison of asymptomatic bacteriuria Escherichia coli isolates from healthy individuals versus those from hospital patients shows that long-term bladder colonization selects for attenuated virulence phenotypes. Infect Immun 2012; 80: 668-678
• 9 Zdziarski J, Brzuszkiewicz E, Wullt B et al. Host imprints on bacterial genomes – rapid, divergent evolution in individual patients. PLoS Pathog 2010; 6 e1001078
• 10 Darouiche RO, Thornby JI, Cerra-Stewart C et al. Bacterial interference for prevention of urinary tract infection: pilot trial. Clin Infect Dis 2005; 41: 1531-1534
• 11 Sundén F, Håkansson L, Ljunggren E et al. Escherichia coli 83972 bacteriuria protects against recurrent lower urinary tract infections in patients with incomplete bladder emptying. J Urol 2010; 184: 179-185
• 12 Hooton TM, Scholes D, Stapleton AE et al. A prospective study of asymptomatic bacteriuria in sexually active young women. N Engl J Med 2000; 343: 992-997
• 13 Cai T, Mazzoli S, Mondaini N et al. The role of asymptomatic bacteriuria in young women with recurrent urinary tract infections: to treat or not to treat?. Clin Infect Dis 2012; 55: 771-777
• 14 Geerlings SE, Stolk RP, Camps MJ et al. Consequences of asymptomatic bacteriuria in women with diabetes mellitus. Arch Intern Med 2001; 161: 1421-1427
• 15 Semetkowska-Jurkiewicz E, Horoszek-Maziarz S, Galiński J et al. The clinical course of untreated asymptomatic bacteriuria in diabetic patients – 14-year follow-up. Mater Med Pol 1995; 27: 91-95
• 16 Harding GKM, Zhanel GG, Nicolle LE et al. Antimicrobial treatment in diabetic women with asymptomatic bacteriuria. N Engl J Med 2002; 347: 1576-1583
• 17 Heinämäki P, Haavisto M, Hakulinen T et al. Mortality in relation to urinary characteristics in the very aged. Gerontology 1986; 32: 167-171
• 18 Nicolle LE, Mayhew WJ, Bryan L. Prospective randomized comparison of therapy and no therapy for asymptomatic bacteriuria in institutionalized elderly women. Am J Med 1987; 83: 27-33
• 19 Warren JW, Anthony WC, Hoopes JM et al. Cephalexin for susceptible bacteriuria in afebrile, long-term catheterized patients. J Am Med Assoc 1982; 248: 454-458
• 20 Buehlmann M, Bruderer T, Frei R et al. Effectiveness of a new decolonisation regimen for eradication of extended-spectrum β-lactamase-producing Enterobacteriaceae. J Hosp Infect 2011; 77: 113-117
• 21 Uncu Y, Uncu G, Esmer A et al. Should asymptomatic bacteriuria be screened in pregnancy?. Clin Exp Obstet Gynecol 2002; 29: 281-285
• 22 Gratacós E, Torres PJ, Vila J et al. Screening and treatment of asymptomatic bacteriuria in pregnancy prevent pyelonephritis. J Infect Dis 1994; 169: 1390-1392
• 23 Gross PA, Patel B. Reducing antibiotic overuse: a call for a national performance measure for not treating asymptomatic bacteriuria. Clin Infect Dis 2007; 45: 1335-1337
• 24 Stenqvist K, Dahlén-Nilsson I, Lidin-Janson G et al. Bacteriuria in pregnancy. Frequency and risk of acquisition. Am J Epidemiol 1989; 129: 372-379
• 25 Leuck A-M, Wright D, Ellingson L et al. Complications of Foley catheters – is infection the greatest risk?. J Urol 2012; 187: 1662-1666
• 26 Jamil F. Towards a catheter free status in neurogenic bladder dysfunction: a review of bladder management options in spinal cord injury (SCI). Spinal cord 2001; 39: 355-361
• 27 Sobel JD, Fisher JF, Kauffman C et al. Candida urinary tract infections – epidemiology. Clin Infect Dis 2011; 52 : 433-436
• 28 Kauffman CA, Fisher JF, Sobel JD et al. Candida urinary tract infections – diagnosis. Clin Infect Dis 2011; 52 : 452-456
• 29 Kauffman CA, Vazquez JA, Sobel JD et al. Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis 2000; 30: 14-18
• 30 Fisher JF, Sobel JD, Kauffman C et al. Candida urinary tract infections – treatment. Clin Infect Dis 2011; 52 (Suppl. 06) 457-466